N&O 100
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Diagnostic Substances Sector (CIX: MSECTOR516)
2,049.88   -36.62 (-1.76%)
Streaming Delayed Price  /  Updated: 8:10 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Sector News
Stories about Diagnostic Substances Sector
 
< Previous 1 2 3 4 Next >
Stocks Extend Gains In Late Trade; Myriad Genetics Up
June 13, 2013
Stocks extended their gains in late trading Thursday following better-than-expected economic data. The S&P 500 gained 1%, the Nasdaq was up 0.9% and the Dow Jones industrial average climbed 0.8%.... Read More
category Intraday Updates
from Investor's Business Daily - Investing RSS
Leerink Swann Downgrades Myriad Genetics (MYGN) to Market Perform
June 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8415147 for the full story. Read More
from StreetInsider.com News Articles
Short Interest Increases 39.7% For MYGN
June 13, 2013
The most recent short interest data has been released by the NASDAQ for the 05/31/2013 settlement date, which shows a 1,741,310 share increase in total short interest for Myriad Genetics, Inc. (MYGN),... Read More
category Stocks
from Market News Video
Piper Jaffray Boosts Myriad Genetics (MYGN) Price Target to $49
June 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8414933 for the full story. Read More
from StreetInsider.com News Articles
Upbeat Retail Sales Lift Markets
June 13, 2013
Retail sales rose more than expected in May to lift the markets during the midday with the Dow gaining 54 points to 15,049. Nasdaq climbed 13 points to 3414. Read More
category Market News
from MarketMinute.com Market Updates
Afternoon Market Gainers
June 13, 2013
Belo (NYSE: BLC ) skyrocketed 27.12 percent to $13.64 after a morning of high-volume trading. An announcement was made that Gannett (NYSE: GCI ) plans to acquire Belo in a deal valued at $2.2 billion.... Read More
category GCI , Benzinga , Movers , and 15 more.
from Latest Articles from Benzinga.com
SurModics Down 13.5% Since SmarTrend Downtrend Call (SRDX)
June 13, 2013
from Comtex SmarTrend® News Briefs
Neogen Has Returned 31.5% Since SmarTrend Recommendation (NEOG)
June 13, 2013
from Comtex SmarTrend® News Briefs
Streetinsider.com's Hot Lunchtime Reads 06/13: (MYGN) (CLSN) (DOLE) (PFE)
June 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8414612 for the full story. Read More
from StreetInsider.com News Articles
Myriad Genetics Trading Higher Today on Above-Average Volume, Consistent With Trend (MYGN)
June 13, 2013
from Comtex SmarTrend® News Briefs
Supreme Court: No patent on human genes
June 13, 2013
The unanimous Supreme Court ruling is a victory for doctors and patients who argued that such patents interfere with scientific research and the practice of medicine. Read More
category Pharmaceuticals , Medical Products , Biotechnology , and 3 more.
from MarketWatch
Supreme Court Rejects Human-Gene Patents -- Sort Of
June 13, 2013
The U.S. Supreme Court today declared human genes off-limits for patent protection, drawing a line between "naturally occurring" DNA sequences and similar genes entirely created in the lab. Read More
category NASDAQ:MYGN
from Forbes Real Time
Downtrend Call Working As OncoGenex Pharmaceutical Stock Falls 15.6% (OGXI)
June 13, 2013
from Comtex SmarTrend® News Briefs
Myriad (MYGN) Issues Response to Supreme Court Decision on Gene Patent
June 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8414253 for the full story. Read More
from StreetInsider.com News Articles
U.S. top court says extracted human DNA cannot be patented
June 13, 2013
WASHINGTON, June 13 (Reuters) - The U.S. Supreme Court on Thursday issued a mixed ruling in a case concerning patents held by Myriad Genetics Inc over the closely watched issue of whether human genes... Read More
category companyNews
from Reuters: Company News
Gene Patent Limited by High Court in Mixed Ruling for Myriad (MYGN)
June 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8414148 for the full story. Read More
from StreetInsider.com News Articles
The Early Movers – who’s hot, who’s not
June 13, 2013
Which RegMed companies are making moves in the 1st hour?  Measuring Early Movers – NEGATIVE…18 red (downs) followed by 6 green (ups)  and 16 blacks (flat).   Signs of life … Verastem (VSTM +$0.43) and... Read More
category Henry McCusker
from Bio-Wire.Com
Myriad Genetics (MYGN) trading paused/halted due to limit up, limit down
June 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8414151 for the full story. Read More
from StreetInsider.com News Articles
Immunomedics Says UCB Offers New Results from Phase 2B Open-Label Extension Study of Epratuzumab in SLE
June 13, 2013
Immunomedics, Inc. (Nasdaq: IMMU ),a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other... Read More
category Benzinga , News , IMMU
from Latest Articles from Benzinga.com
Supreme Court Justices Unanimous on Denying Patents for Human Genes
June 13, 2013
DailyFinance.com : The U.S. Supreme Court issued a unanimous 9-0 ruling today denying patent protection from human genes isolated from the body. In its ruling, the court also ruled that synthetic... Read More
category MYGN
from DailyFinance.com
Examining Options & Block Trading Activity for Myriad Genetics (MYGN)
June 13, 2013
NEW YORK (AVAFIN) -- In an effort to determine if stock trades will be ... Read More
from AVAFIN
Quidel: The Winning Streak Continues (QDEL)
June 12, 2013
from Comtex SmarTrend® News Briefs
Recent 52-Week High Exceeded in Shares of Immunomedics (IMMU)
June 12, 2013
from Comtex SmarTrend® News Briefs
The Early Movers – who’s hot, who’s not
June 12, 2013
Which RegMed companies are making moves in the 1st hour? Measuring Early Movers – POSITIVE…12 green (ups) followed by 9 red (downs) and 19 blacks (flat).   Signs of life … Stemline (STML +$0.29) and... Read More
category Henry McCusker
from Bio-Wire.Com
5 Biotechnology Stocks to Buy Now
June 12, 2013
 Read More
category NASDAQ:INSM , NASDAQ:ARIA , Stocks to Buy , and 3 more.
from InvestorPlace - Latest Headlines
The Early Movers – who’s hot, who’s not
June 11, 2013
Which RegMed companies are making moves in the 1st hour?  Measuring Early Movers – NEGATIVE…23 red (downs) followed by 7 green (ups) and 9 blacks (flat).   Signs of life … ReNeuron (LON: RENE +0.22)... Read More
category Henry McCusker
from Bio-Wire.Com
Immunomedics Announces Combo of 90Y-Epratuzumab-Veltuzumab is Active in Non-Hodgkin Lymphoma
June 11, 2013
Immunomedics, Inc. (Nasdaq: IMMU ),a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other... Read More
category Benzinga , News , FDA , and 1 more.
from Latest Articles from Benzinga.com
Immunomedics (IMMU) Issues Encouraging Update for Epratuzumab w/ 90Y on NHL
June 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8405040 for the full story. Read More
from StreetInsider.com News Articles
Bio-Wire Equity Surveillance – Closing Bell 6/10/2013
June 10, 2013
Monday, June 10th, 2013 DJIA: -.06% to 15,239 S&P 500: -.03% to 1643 NASDAQ: +.13% to 3474 Big pharma (Mkt Cap $10 B+) -.03% Mid-sized pharma ($2-10 B) +.18% Small pharma ($300 M to $2 B) +.91% Micro... Read More
category ACRX , MYGN , ACAD , and 4 more.
from Bio-Wire.Com
Stocks rebound as selling into strengths continue
June 10, 2013
Stuck on RegMed sector perceptions come and go Many time we see something positive in the RegMed sector, such as an Orphan Drug Designation and hope to see a blip <Stemline (STML) – who has also had a... Read More
category Henry McCusker
from Bio-Wire.Com
< Previous 1 2 3 4 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here